Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
2022 · The Journal of Experimental Medicine · 66 citations
https://doi.org/10.1084/jem.20220638
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
443
Citations
12
h-index
13
i10-index
Émilie Giraud is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Research on Leishmaniasis Studies & SARS-CoV-2 and COVID-19 Research & Mosquito-borne diseases and control. The author has an h-index of 12, co-authored 29 publications.
ORCID: 0000-0002-0028-1944https://doi.org/10.1084/jem.20220638
https://doi.org/10.1186/s12866-019-1404-z
Click to start Chat